- Home
- Publications
- Publication Search
- Publication Details
Title
Melanoma in the brain
Authors
Keywords
-
Journal
MELANOMA RESEARCH
Volume 22, Issue 3, Pages 177-183
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-04-11
DOI
10.1097/cmr.0b013e328352dbef
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guidelines for the Initial Management of Metastatic Brain Tumors: Role of Surgery, Radiosurgery, and Radiation Therapy
- (2017) Matthew G. Ewend et al. Journal of the National Comprehensive Cancer Network
- Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
- (2011) Bianca Devitt et al. Pigment Cell & Melanoma Research
- Determinants of survival in patients with brain metastases from cutaneous melanoma
- (2010) M Staudt et al. BRITISH JOURNAL OF CANCER
- Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival
- (2010) Jan Zakrzewski et al. CANCER
- Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma
- (2010) Thomas K. Eigentler et al. CANCER
- Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
- (2010) J. J. Hong et al. CLINICAL CANCER RESEARCH
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
- (2010) Martin Kocher et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of the genome to personalize therapy for melanoma
- (2010) M A Davies et al. ONCOGENE
- Malignant cells facilitate lung metastasis by bringing their own soil
- (2010) D. G. Duda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of the organ microenvironment in brain metastasis
- (2010) Isaiah J. Fidler SEMINARS IN CANCER BIOLOGY
- Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
- (2009) M. A. Davies et al. CLINICAL CANCER RESEARCH
- Chemokine–chemokine receptor axes in melanoma brain metastasis
- (2009) Sivan Izraely et al. IMMUNOLOGY LETTERS
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Targeting protein kinases in central nervous system disorders
- (2009) Laura K. Chico et al. NATURE REVIEWS DRUG DISCOVERY
- A phase II study of thalidomide in patients with brain metastases from malignant melanoma
- (2008) Lene W. Vestermark et al. ACTA ONCOLOGICA
- Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma
- (2008) Michael B. Atkins et al. CANCER
- Molecular Basis for the Critical Role of Suppressor of Cytokine Signaling-1 in Melanoma Brain Metastasis
- (2008) F.-J. Huang et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More